Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 103, Issue 11, Pages 1644-1648
Publisher
Springer Nature
Online
2010-10-27
DOI
10.1038/sj.bjc.6605955
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
- (2010) Hedy Lee Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205
- (2010) Philip A. Philip et al. JOURNAL OF CLINICAL ONCOLOGY
- Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials
- (2010) Ilke Sipahi et al. LANCET ONCOLOGY
- Blocking Angiotensin II Type 1 Receptor Triggers Apoptotic Cell Death in Human Pancreatic Cancer Cells
- (2010) Qiaoke Gong et al. PANCREAS
- The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer
- (2009) V. Fendrich et al. GUT
- Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
- (2009) Stefan Wilop et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer
- (2009) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
- (2009) David Cunningham et al. JOURNAL OF CLINICAL ONCOLOGY
- Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma
- (2009) Hitoshi Yoshiji et al. JOURNAL OF HEPATOLOGY
- Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials
- (2009) Craig I Coleman et al. JOURNAL OF HYPERTENSION
- A Pilot Study for Combination Chemotherapy Using Gemcitabine and S-1 for Advanced Pancreatic Cancer
- (2009) Yousuke Nakai et al. ONCOLOGY
- Does the Renin-Angiotensin System Participate in Regulation of Human Vasculogenesis and Angiogenesis?
- (2008) A. Y. Khakoo et al. CANCER RESEARCH
- The renin-angiotensin system and malignancy
- (2008) E. I. Ager et al. CARCINOGENESIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now